StockClub
GLUEMonte Rosa Therapeutics, Inc.$ --
Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

GLUE

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

analyticsEarnings Summary

FY2025 Q4Updated: 12/31/2025

Revenue

attach_money
3M USD
-

Operating Income

trending_up
-50M USD
-

Net Income

verified
-46M USD
-

EPS

paid
-0.7$
-

Revenue

$2.8M

BEAT
$41.7M
$84.9M
Q1
$7.4M
$23.2M
Q2
$7.4M
$12.8M
Q3
$15.6M
$2.8M
Q4
$72M
$123.7M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-

Net Income

$-46.1M

BEAT
$-173,166
$46.9M
Q1
$-24.7M
$-12.3M
Q2
$-24M
$-27.1M
Q3
$-23M
$-46.1M
Q4
$-71.9M
$-38.6M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-

Surprise History

ActualEstimate
FY2025MISS
$123.7M

Future Forecast